BioSpace News Archive

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal 2021 financial results Friday, February 5, 2021.

- National Cancer Institute (NCI) study investigating zotiraciclib (ZTR) in combination with temozolomide (TMZ) demonstrates meaningful clinical efficacy - ZTR has a favorable safety profile and was found to be well tolerated - Based on positive top-line Phase 1b data, Adastra Pharmaceuticals, Inc. is steadfast in undertaking a registration-enabling clinical study in the first half of 2021

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the Pre-IND meeting requested on 22 December 2020 for HT-001 with the U.S. Food and Drug Administration (FDA) Division of Dermatology and Dental Products has been granted to receive written responses only from FDA that are targeted for delivery on F

Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process. Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between pa

Establishment Labs Announces Participation in the 39 th Annual J.P. Morgan Healthcare Conference

--Study demonstrates the efficacy and therapeutic potential of select ionizable lipid nanoparticles for delivering mRNA to treat genetic diseases before birth--

LabMinds, Inc., a next-generation robotics company focused on solution preparation, announces that Anita Santos has been named as Vice President of Marketing.